Oxford Pharmascience Group

Oxford Pharmascience is a drug development company that re-develops approved drugs using proprietary formulation technologies to make them better, safer and easier to take. Since Oxford Pharmascience's products incorporate previously approved drugs, this reduces risk and results in a simplified drug development regulatory pathway allowing less expensive development programs and faster access to market. The Company's pipeline is focused on cardiovascular disease and pain relief indications addressing unmet patient needs with significant commercial potential in global markets. The company was founded in February'08 and floated in London's AIM market in February 2010.
Company Growth (employees)
Type
Public
HQ
London, GB
Founded
2008
Size (employees)
10 (est)
Oxford Pharmascience Group was founded in 2008 and is headquartered in London, GB

Oxford Pharmascience Group Office Locations

Oxford Pharmascience Group has an office in London
London, GB (HQ)
2 Royal College Street, Camden

Oxford Pharmascience Group Data and Metrics

Oxford Pharmascience Group Financial Metrics

Oxford Pharmascience Group's revenue was reported to be £796 k in FY, 2016 which is a 6% increase from the previous period.
GBP

Revenue (FY, 2016)

796 k

Revenue growth (FY, 2015 - FY, 2016), %

6%

Gross profit (FY, 2016)

200 k

Gross profit margin (FY, 2016), %

25%

Net income (FY, 2016)

(1.4 m)

Market capitalization (26-May-2015)

253.2 b

Closing share price (26-May-2015)

0.2

Cash (31-Dec-2016)

16.9 m
Oxford Pharmascience Group's current market capitalization is $253.2 b.
GBPFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

1 m705 k749 k796 k

Revenue growth, %

(31%)6%6%

Cost of goods sold

693 k482 k591 k596 k

Gross profit

336 k223 k158 k200 k
GBPFY, 2013FY, 2014FY, 2015FY, 2016

Cash

9.9 m6.7 m13.1 m16.9 m

Accounts Receivable

108 k215 k179 k343 k

Current Assets

10.2 m7.6 m24.1 m22.7 m

PP&E

5 k5 k4 k2 k
GBPFY, 2013FY, 2014FY, 2015FY, 2016

Cash From Operating Activities

(1.2 m)(3.4 m)(3.2 m)(1.3 m)

Cash From Financing Activities

8.9 m157 k19.4 m

Income Taxes Paid

49 k600 k763 k514 k
Y, 2016

Financial Leverage

1 x
Show all financial metrics

Traffic Overview of Oxford Pharmascience Group

Oxford Pharmascience Group Company Life and Culture

You may also be interested in